Cargando…
Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
Nonalcoholic fatty liver disease (NAFLD) is a rising indication for liver transplantation (LT). Identification of NAFLD recurrence and those at risk for more progressive disease after LT remains elusive as the diagnosis requires biopsy, which is invasive and impractical for serial monitoring. We the...
Autores principales: | Mowry, Christopher J., Alonso, Cristina, Iruarrizaga-Lejarreta, Marta, Ortiz, Pablo, Levitsky, Josh, Rinella, Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580200/ https://www.ncbi.nlm.nih.gov/pubmed/34778544 http://dx.doi.org/10.1097/TXD.0000000000001227 |
Ejemplares similares
-
Resting and Exercise Energy Metabolism After Liver Transplantation for Nonalcoholic Steatohepatitis
por: Levitsky, Josh, et al.
Publicado: (2017) -
An Unusual Cause of Acute Pancreatitis in a Liver Transplant Recipient
por: Nizamuddin, Imran, et al.
Publicado: (2021) -
Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
por: Satapathy, Sanjaya K., et al.
Publicado: (2020) -
Poor Practitioner Adherence to Clinical Tobacco Use Guidelines in Liver Transplant Recipients
por: Harrington, Claire, et al.
Publicado: (2022) -
Comanagement With Nephrologist Care Is Associated With Fewer Cardiovascular Events Among Liver Transplant Recipients With Chronic Kidney Disease
por: Campbell, Patrick T., et al.
Publicado: (2021)